MarketPulse — Real-Time Financial News & Market Analysis

Pepeto launches Binance-level exchange as Ethereum crashes to $2,070 but spot ETFs see $157M daily inflows. Analysts target $7,500 ETH by 2026.

Rosen Law Firm seeks lead plaintiffs in securities lawsuit against Aquestive Therapeutics over alleged false statements regarding Anaphylm drug application.

$SNOW faces class action lawsuit over alleged misstatements on product efficiency, Iceberg Tables, and storage pricing. Stock fell 18% when revenue headwinds disclosed.

NuScale Power faces securities fraud lawsuit over alleged misstatements about ENTRA1 Energy partnership. Stock fell 14.4% after $495M payment disclosure; April 20, 2026 lead plaintiff deadline.

ServiceNow stock down 25% amid SaaS AI fears, but $NOW positioned as AI leader with Now Assist reaching $600M ACV, projected $1B by year-end.

Chevron emerges as better long-term investment over Occidental, offering diversified operations, stronger dividend history, and clearer growth visibility through 2030.

Pepeto launches ecosystem expansion with DeFi and AI features. Elon Musk's X Money crypto launch boosts Dogecoin 8%. Bitcoin stabilizes near $69,200 after recent volatility.

Pepeto launches AI-powered security upgrade for decentralized exchange. XRP targets $5-$10 as large holders join Pepeto presale ahead of rumored Binance listing.

Aldeyra Therapeutics stock plunged 71% after FDA rejected its reproxalap dry eye drug, prompting a securities investigation by Rosen Law Firm.

DNOW Inc. stock fell 19.1% following disappointing Q4 2025 results that missed expectations, triggering securities investigation and class action lawsuit.

Amazon plans $200B AI infrastructure spending in 2026—53% above analyst estimates—risking shareholder returns if deployment disappoints.

Beyond Meat relocates products from refrigerated to frozen sections at Walmart and Costco, signaling fading plant-based demand and ongoing profitability struggles.

Soleno Therapeutics faces class action lawsuit over alleged failure to disclose safety issues with drug DCCR, following 12-27% stock declines from August-September 2025 revelations.

Cameco positioned as key uranium supplier amid U.S. nuclear expansion plans, with 39% projected annual EPS growth through 2028 despite recent valuation concerns.

BofA MOVE Index surges 28% to 108.84, highest since April 2025, signaling potential stock market volatility amid geopolitical tensions and inflation concerns.

TRX Gold shares jump 42% YTD on record Tanzanian production and 40% revenue growth to $57.6M. Expansion plans and cost efficiency offer upside, but single-asset concentration poses risk.

Schall Law Firm seeks investors in $LU securities lawsuit, alleging Lufax made false statements and failed internal controls between April 2023 and January 2025.

Bridger Management sold its $7M Masimo stake after 12% decline; weeks later, a $9.9B acquisition sparked 34% surge, highlighting investment timing risks.

AI stocks face a painful but historically productive "trough of disillusionment." Oracle and Alphabet positioned for 2026 recovery as investor reset creates potential generational buying opportunity.

U.S. gas prices spike 30% to $3.88/gallon amid global crude surge. Domestic refineries' inability to process light sweet crude forces reliance on imported heavy oil, tying American pump prices to global markets.